WCX

4-{5-[(1-METHYLPIPERIDIN-4-YL)OXY]-1H-BENZIMIDAZOL-1-YL}-2-{(1R)-1-[2-(TRIFLUOROMETHYL)PHENYL]ETHOXY}BENZAMIDE

Created:	2010-08-05
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where WCX is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	68
Chiral Atom Count	1
Bond Count	72
Aromatic Bond Count	23

2D diagram of WCX

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-{5-[(1-METHYLPIPERIDIN-4-YL)OXY]-1H-BENZIMIDAZOL-1-YL}-2-{(1R)-1-[2-(TRIFLUOROMETHYL)PHENYL]ETHOXY}BENZAMIDE
Systematic Name (OpenEye OEToolkits)	4-[5-(1-methylpiperidin-4-yl)oxybenzimidazol-1-yl]-2-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]benzamide
Formula	C₂₉ H₂₉ F₃ N₄ O₃
Molecular Weight	538.561
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	FC(F)(F)c1ccccc1C(Oc2c(C(=O)N)ccc(c2)n4c5ccc(OC3CCN(C)CC3)cc5nc4)C
SMILES	CACTVS	3.352	C[CH](Oc1cc(ccc1C(N)=O)n2cnc3cc(OC4CCN(C)CC4)ccc23)c5ccccc5C(F)(F)F
SMILES	OpenEye OEToolkits	1.6.1	CC(c1ccccc1C(F)(F)F)Oc2cc(ccc2C(=O)N)n3cnc4c3ccc(c4)OC5CCN(CC5)C
Canonical SMILES	CACTVS	3.352	C[C@@H](Oc1cc(ccc1C(N)=O)n2cnc3cc(OC4CCN(C)CC4)ccc23)c5ccccc5C(F)(F)F
Canonical SMILES	OpenEye OEToolkits	1.6.1	C[C@H](c1ccccc1C(F)(F)F)Oc2cc(ccc2C(=O)N)n3cnc4c3ccc(c4)OC5CCN(CC5)C
InChI	InChI	1.03	InChI=1S/C29H29F3N4O3/c1-18(22-5-3-4-6-24(22)29(30,31)32)38-27-15-19(7-9-23(27)28(33)37)36-17-34-25-16-21(8-10-26(25)36)39-20-11-13-35(2)14-12-20/h3-10,15-18,20H,11-14H2,1-2H3,(H2,33,37)/t18-/m1/s1
InChIKey	InChI	1.03	FASALJZFFLCNKM-GOSISDBHSA-N

Related Resource References

Resource Name	Reference
PubChem	50990894
ChEMBL	CHEMBL1615277

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.